ALPEK (ALPEKA) Institutional presentation summary
Event summary combining transcript, slides, and related documents.
Institutional presentation summary
5 Aug, 2026Market leadership and business segments
Holds top positions in polyester, plastics & chemicals, and emerging businesses, with 2025 revenues of $6.6B USD and 71% of sales from polyester products.
Operates in 9 countries with 30 plants and over 5,000 employees, focusing on PET resin, sheet, EPS, and recycled PET.
End-markets are resilient, with 87% of volume in food, beverage, and consumer goods; 95% of sales are dollar-based and 64% are outside Mexico.
Strategic initiatives and operational performance
Multi-year strategy focuses on strengthening core business, growing value-added products, and maintaining financial flexibility.
Recent actions include footprint optimization, cost reduction, asset sales, and expansion into Brazil and energy commercialization.
2026 initiatives prioritized competitive asset optimization, high-value product expansion, and strong balance sheet management, achieving a leverage ratio of 2.2x ahead of schedule.
Financial results and guidance
2025 revenues reached $6.6B, with 2026 YTD sales volume at 4.38M tons and comparable EBITDA guidance revised to $750–800M.
Operating free cash flow for 2026 YTD is $217M, with disciplined debt reduction and net debt at $1.66B.
CAPEX for 2026 is projected at $150M, and dividend payments are suspended to maintain leverage targets.
Latest events from ALPEK
- Market leadership, financial strength, and sustainability drive growth in polyester and PET.ALPEKA
Institutional presentation - EBITDA up 300% YoY in Q2 2026, leverage improved to 2.2x, and guidance was raised.ALPEKA
Q2 2026 - EBITDA surged 50% sequentially, with improved leverage and strong segment performance.ALPEKA
Q1 2026 - 2025 EBITDA dropped 30% to $489M, but free cash flow rose 57%; 2026 outlook targets $450–$500M EBITDA.ALPEKA
Q4 2025 - Lower earnings and revised guidance amid global oversupply, tariffs, and operational disruptions.ALPEKA
Q2 2025 - Q3 delivered record EBITDA, raised guidance, and progress on spin-off and cost savings.ALPEKA
Q3 2024 - Stable volumes, $75M cost savings, and lower leverage support 2024 guidance.ALPEKA
Q2 2024 - 1Q25 volume and EBITDA fell on overcapacity, but strategic initiatives and cash flow improved.ALPEKA
Q1 2025 - 2024 EBITDA beat guidance, cost savings hit $75M, and leverage improved to 2.9x.ALPEKA
Q4 2024